Potential of Parameters of Iron Metabolism for the Diagnosis of Anemia of Inflammation in the Critically Ill

Background: Anemia of inflammation (AI) is the most common cause of anemia in the critically ill, but its diagnosis is a challenge. New therapies specific to AI are in development, and they require accurate detection of AI. This study explores the potential of parameters of iron metabolism for the diagnosis of AI during an ICU stay. Methods: In a nested case-control study, 30 patients developing AI were matched to 60 controls. The iron parameters were determined in plasma samples during an ICU stay. Receiver operating characteristic curves were used to determine the iron parameter threshold with the highest sensitivity and specificity to predict AI. Likelihood ratios as well as positive and negative predictive values were calculated as well. Results: The sensitivity of iron parameters for diagnosing AI ranges between 62 and 76%, and the specificity between 57 and 72%. Iron and transferrin show the greatest area under the curve. Iron shows the highest sensitivity, and transferrin and transferrin saturation display the highest specificity. Hepcidin and ferritin show the lowest specificity. At an actual anemia prevalence of 53%, the diagnostic accuracy of iron, transferrin, and transferrin saturation was fair, with a positive predictive value between 71 and 73%. Combining iron, transferrin, transferrin saturation, hepcidin, and/or ferritin levels did not increase the accuracy of the AI diagnosis. Conclusions: In this explorative study on the use of different parameters of iron metabolism for diagnosing AI during an ICU stay, low levels of commonly measured markers such as plasma iron, transferrin, and transferrin saturation have the highest sensitivity and specificity and outperform ferritin and hepcidin.

[1]  J. Binnekade,et al.  Iron metabolism in critically ill patients developing anemia of inflammation: a case control study , 2017, Annals of Intensive Care.

[2]  T. van der Poll,et al.  Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis. , 2016, JAMA.

[3]  R. J. MacKay,et al.  Comparing two binary diagnostic tests with repeated measurements , 2016 .

[4]  D. Swinkels,et al.  Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans. , 2014, Blood.

[5]  D. Swinkels,et al.  Serum hepcidin measured by immunochemical and mass-spectrometric methods and their correlation with iron status indicators in healthy children aged 0.5–3 y , 2014, Pediatric Research.

[6]  T. Ganz,et al.  Anemia of inflammation. , 2014, Hematology/oncology clinics of North America.

[7]  S. Lehmann,et al.  Clinical measurement of Hepcidin-25 in human serum: Is quantitative mass spectrometry up to the job? , 2014 .

[8]  J. Isaacs,et al.  Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis , 2013, Arthritis Research & Therapy.

[9]  K. Yoshizaki,et al.  Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients , 2013, Arthritis Research & Therapy.

[10]  S. Sell,et al.  The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys. , 2013, Blood.

[11]  J. P. McCoy,et al.  Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects. , 2012, Cytokine.

[12]  D. Prakash.  Anemia in the ICU: anemia of chronic disease versus anemia of acute illness. , 2012, Critical care clinics.

[13]  D. Swinkels,et al.  Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. , 2011, Arthritis and rheumatism.

[14]  Gary King,et al.  MatchIt: Nonparametric Preprocessing for Parametric Causal Inference , 2011 .

[15]  U. Kobold,et al.  Serum hepcidin‐25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients , 2011, International journal of laboratory hematology.

[16]  I. Boutron,et al.  Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia , 2010, Intensive Care Medicine.

[17]  Philip S Barie,et al.  Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care* , 2009, Critical care medicine.

[18]  M. Mohri,et al.  Effects of heparin, citrate, and EDTA on plasma biochemistry of sheep: comparison with serum. , 2009, Research in veterinary science.

[19]  P. Marik,et al.  Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature* , 2008, Critical care medicine.

[20]  K. Sihler,et al.  Anemia of Inflammation in Critically Ill Patients , 2008, Journal of intensive care medicine.

[21]  Yvonne Vergouwe,et al.  Bmc Medical Research Methodology Open Access Advantages of the Nested Case-control Design in Diagnostic Research , 2022 .

[22]  Johannes B Reitsma,et al.  Case-control and two-gate designs in diagnostic accuracy studies. , 2005, Clinical chemistry.

[23]  M. Levy,et al.  The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States* , 2004, Critical care medicine.

[24]  Tomas Ganz,et al.  Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. , 2003, Blood.

[25]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[26]  J. Vincent,et al.  Anemia and blood transfusion in critically ill patients. , 2002, JAMA.

[27]  G. Palomaki,et al.  Reference distributions for the negative acute‐phase serum proteins, albumin, transferrin and transthyretin: A practical, simple and clinically relevant approach in a large cohort , 1999, Journal of clinical laboratory analysis.